Ana Crespo

Targeting shared molecular etiologies to accelerate drug development for rare diseases

P. J. Brooks, R. Nabbout, Chun‐Hung Chan, 2023, EMBO molecular medicine.

Pancreatic steatosis and iron overload increases cardiovascular risk in non-alcoholic fatty liver disease

L. Martí-Bonmatí, Á. Alberich-Bayarri, Ana Jiménez-Pastor, 2023, Frontiers in endocrinology.